{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T06:01:09Z","timestamp":1760853669573},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,4,25]],"date-time":"2013-04-25T00:00:00Z","timestamp":1366848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"},{"start":{"date-parts":[[2013,4,25]],"date-time":"2013-04-25T00:00:00Z","timestamp":1366848000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/srep01734","type":"journal-article","created":{"date-parts":[[2013,4,25]],"date-time":"2013-04-25T05:03:44Z","timestamp":1366866224000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["A Whole Cell Pathway Screen Reveals Seven Novel Chemosensitizers to Combat Chloroquine Resistant Malaria"],"prefix":"10.1038","volume":"3","author":[{"given":"Jun-Hong","family":"Ch'ng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sachel","family":"Mok","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zbynek","family":"Bozdech","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin James","family":"Lear","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aicha","family":"Boudhar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruce","family":"Russell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francois","family":"Nosten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin Shyong-Wei","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,4,25]]},"reference":[{"key":"BFsrep01734_CR1","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.parint.2009.04.004","volume":"58","author":"T Mita","year":"2009","unstructured":"Mita, T., Tanabe, K. & Kita, K. Spread and evolution of Plasmodium falciparum drug resistance. Parasitol Int 58, 201\u2013209 (2009).","journal-title":"Parasitol Int"},{"key":"BFsrep01734_CR2","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1056\/NEJMoa0808859","volume":"361","author":"AM Dondorp","year":"2009","unstructured":"Dondorp, A. M. et al. Artemisinin Resistance in Plasmodium falciparum Malaria. New England Journal of Medicine 361, 455\u2013467 (2009).","journal-title":"New England Journal of Medicine"},{"key":"BFsrep01734_CR3","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1126\/science.1193225","volume":"329","author":"M Rottmann","year":"2010","unstructured":"Rottmann, M. et al. Spiroindolones, a potent compound class for the treatment of malaria. Science 329, 1175\u20131180 (2010).","journal-title":"Science"},{"key":"BFsrep01734_CR4","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1054\/drup.2000.0157","volume":"3","author":"AB Vaidya","year":"2000","unstructured":"Vaidya, A. B. & Mather, M. W. Atovaquone resistance in malaria parasites. Drug Resist Updat 3, 283\u2013287 (2000).","journal-title":"Drug Resist Updat"},{"key":"BFsrep01734_CR5","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1097\/QCO.0b013e3282f1673a","volume":"20","author":"TJ Egan","year":"2007","unstructured":"Egan, T. J. & Kaschula, C. H. Strategies to reverse drug resistance in malaria. Curr Opin Infect Dis 20, 598\u2013604 (2007).","journal-title":"Curr Opin Infect Dis"},{"key":"BFsrep01734_CR6","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.pt.2012.02.005","volume":"28","author":"JH Ch'ng","year":"2012","unstructured":"Ch'ng, J. H., Renia, L., Nosten, F. & Tan, K. S. Can we teach an old drug new tricks? Trends Parasitol 28, 220\u2013224 (2012).","journal-title":"Trends Parasitol"},{"key":"BFsrep01734_CR7","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.drup.2006.09.002","volume":"9","author":"DA van Schalkwyk","year":"2006","unstructured":"van Schalkwyk, D. A. & Egan, T. J. Quinoline-resistance reversing agents for the malaria parasite Plasmodium falciparum. Drug Resist Updat 9, 211\u2013226 (2006).","journal-title":"Drug Resist Updat"},{"key":"BFsrep01734_CR8","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1038\/nrmicro2331","volume":"8","author":"AM Dondorp","year":"2010","unstructured":"Dondorp, A. M. et al. Artemisinin resistance: current status and scenarios for containment. Nat Rev Microbiol 8, 272\u2013280 (2010).","journal-title":"Nat Rev Microbiol"},{"key":"BFsrep01734_CR9","doi-asserted-by":"publisher","first-page":"4075","DOI":"10.1128\/AAC.48.11.4075-4083.2004","volume":"48","author":"JK Baird","year":"2004","unstructured":"Baird, J. K. Chloroquine resistance in Plasmodium vivax. Antimicrob Agents Chemother 48, 4075\u20134083 (2004).","journal-title":"Antimicrob Agents Chemother"},{"key":"BFsrep01734_CR10","doi-asserted-by":"publisher","first-page":"4623","DOI":"10.1016\/0006-2952(88)90330-9","volume":"37","author":"AS Gross","year":"1988","unstructured":"Gross, A. S., Heuer, B. & Eichelbaum, M. Stereoselective protein binding of verapamil enantiomers. Biochem Pharmacol 37, 4623\u20134627 (1988).","journal-title":"Biochem Pharmacol"},{"key":"BFsrep01734_CR11","doi-asserted-by":"publisher","first-page":"3115","DOI":"10.1128\/AAC.01566-10","volume":"55","author":"MR Pereira","year":"2011","unstructured":"Pereira, M. R. et al. In vivo and in vitro antimalarial properties of azithromycin-chloroquine combinations that include the resistance reversal agent amlodipine. Antimicrob Agents Chemother 55, 3115\u20133124 (2011).","journal-title":"Antimicrob Agents Chemother"},{"key":"BFsrep01734_CR12","doi-asserted-by":"publisher","first-page":"563","DOI":"10.2174\/156802608783955593","volume":"8","author":"M Henry","year":"2008","unstructured":"Henry, M., Alibert, S., Rogier, C., Barbe, J. & Pradines, B. Inhibition of efflux of quinolines as new therapeutic strategy in malaria. Curr Top Med Chem 8, 563\u2013578 (2008).","journal-title":"Curr Top Med Chem"},{"key":"BFsrep01734_CR13","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1179\/136485908X252179","volume":"102","author":"GO Gbotosho","year":"2008","unstructured":"Gbotosho, G. O. et al. Comparative study of interactions between chloroquine and chlorpheniramine or promethazine in healthy volunteers: a potential combination-therapy phenomenon for resuscitating chloroquine for malaria treatment in Africa. Ann Trop Med Parasitol 102, 3\u20139 (2008).","journal-title":"Ann Trop Med Parasitol"},{"key":"BFsrep01734_CR14","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/S1097-2765(05)00077-8","volume":"6","author":"DA Fidock","year":"2000","unstructured":"Fidock, D. A. et al. Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance. Mol Cell 6, 861\u2013871 (2000).","journal-title":"Mol Cell"},{"key":"BFsrep01734_CR15","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1128\/AAC.32.6.799","volume":"32","author":"DJ Krogstad","year":"1988","unstructured":"Krogstad, D. J., Schlesinger, P. H. & Herwaldt, B. L. Antimalarial agents: mechanism of chloroquine resistance. Antimicrob Agents Chemother 32, 799\u2013801 (1988).","journal-title":"Antimicrob Agents Chemother"},{"key":"BFsrep01734_CR16","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1186\/1475-2875-8-294","volume":"8","author":"S Karl","year":"2009","unstructured":"Karl, S., Wong, R. P., St Pierre, T. G. & Davis, T. M. A comparative study of a flow-cytometry-based assessment of in vitro Plasmodium falciparum drug sensitivity. Malar J 8, 294 (2009).","journal-title":"Malar J"},{"key":"BFsrep01734_CR17","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1038\/srep00118","volume":"1","author":"B Malleret","year":"2011","unstructured":"Malleret, B. et al. A rapid and robust tri-color flow cytometry assay for monitoring malaria parasite development. Sci Rep 1, 118 (2011).","journal-title":"Sci Rep"},{"key":"BFsrep01734_CR18","doi-asserted-by":"publisher","first-page":"e26","DOI":"10.1038\/cddis.2010.2","volume":"1","author":"JH Ch'ng","year":"2010","unstructured":"Ch'ng, J. H., Kotturi, S. R., Chong, A. G., Lear, M. J. & Tan, K. S. A programmed cell death pathway in the malaria parasite Plasmodium falciparum has general features of mammalian apoptosis but is mediated by clan CA cysteine proteases. Cell Death Dis 1, e26 (2010).","journal-title":"Cell Death Dis"},{"key":"BFsrep01734_CR19","doi-asserted-by":"publisher","first-page":"e216","DOI":"10.1038\/cddis.2011.97","volume":"2","author":"JH Ch'ng","year":"2011","unstructured":"Ch'ng, J. H., Liew, K., Goh, A. S., Sidhartha, E. & Tan, K. S. Drug-induced permeabilization of parasite's digestive vacuole is a key trigger of programmed cell death in Plasmodium falciparum. Cell Death Dis 2, e216 (2011).","journal-title":"Cell Death Dis"},{"key":"BFsrep01734_CR20","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/S1471-4922(02)02365-6","volume":"18","author":"DG Spiller","year":"2002","unstructured":"Spiller, D. G., Bray, P. G., Hughes, R. H., Ward, S. A. & White, M. R. The pH of the Plasmodium falciparum digestive vacuole: holy grail or dead-end trail? Trends Parasitol 18, 441\u2013444 (2002).","journal-title":"Trends Parasitol"},{"key":"BFsrep01734_CR21","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1002\/med.10016","volume":"22","author":"LM Ursos","year":"2002","unstructured":"Ursos, L. M. & Roepe, P. D. Chloroquine resistance in the malarial parasite, Plasmodium falciparum. Med Res Rev 22, 465\u2013491 (2002).","journal-title":"Med Res Rev"},{"key":"BFsrep01734_CR22","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/S0166-6851(00)00262-0","volume":"110","author":"LM Ursos","year":"2000","unstructured":"Ursos, L. M., Dzekunov, S. M. & Roepe, P. D. The effects of chloroquine and verapamil on digestive vacuolar pH of P. falciparum either sensitive or resistant to chloroquine. Mol Biochem Parasitol 110, 125\u2013134 (2000).","journal-title":"Mol Biochem Parasitol"},{"key":"BFsrep01734_CR23","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1021\/ci0200265","volume":"42","author":"AK Bhattacharjee","year":"2002","unstructured":"Bhattacharjee, A. K., Kyle, D. E., Vennerstrom, J. L. & Milhous, W. K. A 3D QSAR pharmacophore model and quantum chemical structure-activity analysis of chloroquine(CQ)-resistance reversal. J Chem Inf Comp Sci 42, 1212\u20131220 (2002).","journal-title":"J Chem Inf Comp Sci"},{"key":"BFsrep01734_CR24","doi-asserted-by":"crossref","first-page":"25664","DOI":"10.1016\/S0021-9258(18)35657-6","volume":"267","author":"TM Fong","year":"1992","unstructured":"Fong, T. M., Huang, R. R. & Strader, C. D. Localization of agonist and antagonist binding domains of the human neurokinin-1 receptor. J Biol Chem 267, 25664\u201325667 (1992).","journal-title":"J Biol Chem"},{"key":"BFsrep01734_CR25","doi-asserted-by":"publisher","first-page":"405","DOI":"10.2165\/00003088-199835060-00001","volume":"35","author":"HA Welker","year":"1998","unstructured":"Welker, H. A., Wiltshire, H. & Bullingham, R. Clinical pharmacokinetics of mibefradil. Clin Pharmacokinet 35, 405\u2013423 (1998).","journal-title":"Clin Pharmacokinet"},{"key":"BFsrep01734_CR26","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1126\/science.1205216","volume":"333","author":"J Yuan","year":"2011","unstructured":"Yuan, J. et al. Chemical genomic profiling for antimalarial therapies, response signatures and molecular targets. Science 333, 724\u2013729 (2011).","journal-title":"Science"},{"key":"BFsrep01734_CR27","doi-asserted-by":"publisher","first-page":"343","DOI":"10.2165\/00003088-200140050-00003","volume":"40","author":"PT Giao","year":"2001","unstructured":"Giao, P. T. & de Vries, P. J. Pharmacokinetic interactions of antimalarial agents. Clin Pharmacokinet 40, 343\u2013373 (2001).","journal-title":"Clin Pharmacokinet"},{"key":"BFsrep01734_CR28","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.molbiopara.2003.08.010","volume":"133","author":"P Hunt","year":"2004","unstructured":"Hunt, P., Cravo, P. V., Donleavy, P., Carlton, J. M. & Walliker, D. Chloroquine resistance in Plasmodium chabaudi: are chloroquine-resistance transporter (crt) and multi-drug resistance (mdr1) orthologues involved? Mol Biochem Parasitol 133, 27\u201335 (2004).","journal-title":"Mol Biochem Parasitol"},{"key":"BFsrep01734_CR29","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1093\/infdis\/jiq036","volume":"203","author":"A Ecker","year":"2011","unstructured":"Ecker, A., Lakshmanan, V., Sinnis, P., Coppens, I. & Fidock, D. A. Evidence that mutant PfCRT facilitates the transmission to mosquitoes of chloroquine-treated Plasmodium gametocytes. J Infect Dis 203, 228\u2013236 (2011).","journal-title":"J Infect Dis"},{"key":"BFsrep01734_CR30","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/1471-2164-13-106","volume":"13","author":"K Kinga Modrzynska","year":"2012","unstructured":"Kinga Modrzynska, K. et al. Quantitative genome re-sequencing defines multiple mutations conferring chloroquine resistance in rodent malaria. BMC Genomics 13, 106 (2012).","journal-title":"BMC Genomics"},{"key":"BFsrep01734_CR31","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/0014-4894(92)90040-H","volume":"74","author":"A Miki","year":"1992","unstructured":"Miki, A., Tanabe, K., Nakayama, T., Kiryon, C. & Ohsawa, K. Plasmodium chabaudi: association of reversal of chloroquine resistance with increased accumulation of chloroquine in resistant parasites. Exp Parasitol 74, 134\u2013142 (1992).","journal-title":"Exp Parasitol"},{"key":"BFsrep01734_CR32","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/S0001-706X(00)00133-9","volume":"77","author":"N Singh","year":"2000","unstructured":"Singh, N. & Puri, S. K. Interaction between chloroquine and diverse pharmacological agents in chloroquine resistant Plasmodium yoelii nigeriensis. Acta Trop 77, 185\u2013193 (2000).","journal-title":"Acta Trop"},{"key":"BFsrep01734_CR33","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.1021\/jm020379v","volume":"46","author":"Y Osa","year":"2003","unstructured":"Osa, Y. et al. Structural properties of dibenzosuberanylpiperazine derivatives for efficient reversal of chloroquine resistance in Plasmodium chabaudi. J Med Chem 46, 1948\u20131956 (2003).","journal-title":"J Med Chem"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep01734","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep01734.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep01734.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,6]],"date-time":"2023-01-06T00:35:21Z","timestamp":1672965321000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep01734"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4,25]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2013,12,20]]}},"alternative-id":["BFsrep01734"],"URL":"https:\/\/doi.org\/10.1038\/srep01734","relation":{},"ISSN":["2045-2322"],"issn-type":[{"type":"electronic","value":"2045-2322"}],"subject":[],"published":{"date-parts":[[2013,4,25]]},"assertion":[{"value":"15 February 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2013","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2013","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"K.S.W.T. and M.J.L. are founding directors of BioLynx Technologies, a private company that focuses on fluorophore-conjugated antimalarials. However, the tool (CM-CQ) used in this study is currently not a commercial entity. Other authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1734"}}